Today, Wacker Chemie AG’s Supervisory Board re-appointed Dr. Rudolf Staudigl (63), President & CEO, thereby considering Staudigl’s request for a three-year term.
Wacker Chemie AG substantially increased its sales and EBITDA in the third quarter of 2017, both year over year and quarter over quarter.
Wacker Chemie AG is expanding its existing production plants for polymer binders in South Korea.
At Supply Side West 2017, WACKER is presenting new results on the effect of its nature-identical hydroxytyrosol HTEssence® on heart health.
After the incident at WACKER’s US production site in Charleston, Tennessee, already reported on, root-cause investigation work is now well underway.